| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.41 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |